相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Study on Human Tracheal Bronchial Epithelial Cells Secreting Cytokines in Vitro by Nontypeable Haemophilus Influenzae
Jianmei Qian et al.
CHEST (2011)
Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone
Susumu Hirao et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2011)
Efficacy of Clarithromycin against Experimentally Induced Pneumonia Caused by Clarithromycin-Resistant Haemophilus influenzae in Mice
Shigeki Nakamura et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
A murine model of sepsis following smoke inhalation injury
Matthias Lange et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications
Soichiro Kanoh et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Protective Role of Interleukin-10 in Ozone-Induced Pulmonary Inflammation
Gillian S. Backus et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2010)
Antimicrobial and immunomodulatory effect of clarithromycin on macrolide-resistant Mycoplasma pneumoniae
Satoshi Kurata et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2010)
Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells
Kathryn Chmura et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Effects of telithromycin in in vitro and in vivo models of lipopolysaccharide-induced airway inflammation
Magdalena Leiva et al.
CHEST (2008)
The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection
C. Tagliabue et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Roxithromycin favorably modifies the initial phase of resistance against infection with macrolide-resistant Streptococcus pneumoniae in a murine pneumonia model
Yasuki Yasuda et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Microbiologic and immunologic evaluation of a single high dose of azithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia
AM Ríos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Anti-inflammatory effects of macrolides - an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
GW Amsden
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Effect of multiple doses of clarithromycin and amoxicillin on IL-6, IFNγ and IL-10 plasma levels in patients with community acquired pneumonia
G Demartini et al.
JOURNAL OF CHEMOTHERAPY (2004)
Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection
AM Ríos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults
KA Rodvold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Antimicrobial and immunologic activities of clarithromycin in a murine model of Mycoplasma pneumoniae-induced pneumonia
RD Hardy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Addition of a macrolide to a β-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia
JA Martínez et al.
CLINICAL INFECTIOUS DISEASES (2003)
Effect of macrolide antibiotics on human endothelial cells activated by Chlamydia pneumoniae infection and tumor necrosis factor-α
SM Uriarte et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Effect of telithromycin (HMR 3647) on polymorphonuclear neutrophil killing of Staphylococcus aureus in comparison with roxithromycin
D Vazifeh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Pharmacokinetic-pharmacodynamic modeling of the inhibitory effect of erythromycin on tumour necrosis factor-α and interleukin-6 production
HJ Guchelaar et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2001)
Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia
GW Waterer et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Empiric antibiotic therapy anal mortality among Medicare pneumonia inpatients in 10 western states - 1993, 1995, and 1997
PM Houck et al.
CHEST (2001)
Kinetic study of the inflammatory response in Streptococcus pneumoniae experimental pneumonia treated with the ketolide HMR 3004
M Duong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Subinhibitory concentrations of erythromycin reduce pneumococcal adherence to respiratory epithelial cells in vitro
K Lagrou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Intravenous infusion of erythromycin inhibits CXC chemokine production, but augments neutrophil degranulation in whole blood stimulated with Streptococcus pneumoniae
MJ Schultz et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Apoptosis, oxidative metabolism and interleukin-8 production in human neutrophils exposed to azithromycin:: effects of Streptococcus pneumoniae
CC Koch et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: A survey of nonteaching US community hospitals
V Dudas et al.
ANNALS OF PHARMACOTHERAPY (2000)
分享论文
